Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Reichert

Showing results (21-30 of 437) with videos related to

Pageof 44
Sort By:
Mabs|January 13, 2010
mAb therapeutic products and risk managementJanice M Reichert
Mabs|January 13, 2010
Letter from the editorJanice M Reichert
Archives of Pathology & Laboratory Medicine|November 1, 1992
New safety considerations for the acquired immunodeficiency syndrome autopsyC M Reichert
Trends in Biotechnology|June 9, 2006
Trends in US approvals: new biopharmaceuticals and vaccinesJanice M Reichert
Mabs|November 29, 2013
Note of appreciation to reviewersJanice M Reichert
Mabs|December 15, 2015
Antibodies to watch in 2016Janice M Reichert
Current Opinion in Molecular Therapeutics|June 5, 2002
Therapeutic monoclonal antibodies: trends in development and approval in the USJanice M Reichert
Medecine Sciences : M/S|January 7, 2020
[Antibody therapeutics: an American view of an amazing present and future]Janice M Reichert
Mabs|March 2, 2011
Letter from the Editor: stratified medicineJanice M Reichert
Mabs|June 10, 2011
Bispecific antibodies and ADCs: Once and future kings?Janice M Reichert
Pageof 44

Showing results (21-30 of 437) with videos related to

Sort By:
Pageof 44
Mabs|January 13, 2010
mAb therapeutic products and risk managementJanice M Reichert
Mabs|January 13, 2010
Letter from the editorJanice M Reichert
Archives of Pathology & Laboratory Medicine|November 1, 1992
New safety considerations for the acquired immunodeficiency syndrome autopsyC M Reichert
Trends in Biotechnology|June 9, 2006
Trends in US approvals: new biopharmaceuticals and vaccinesJanice M Reichert
Mabs|November 29, 2013
Note of appreciation to reviewersJanice M Reichert
Mabs|December 15, 2015
Antibodies to watch in 2016Janice M Reichert
Current Opinion in Molecular Therapeutics|June 5, 2002
Therapeutic monoclonal antibodies: trends in development and approval in the USJanice M Reichert
Medecine Sciences : M/S|January 7, 2020
[Antibody therapeutics: an American view of an amazing present and future]Janice M Reichert
Mabs|March 2, 2011
Letter from the Editor: stratified medicineJanice M Reichert
Mabs|June 10, 2011
Bispecific antibodies and ADCs: Once and future kings?Janice M Reichert
Pageof 44